{"id":"NCT01553591","sponsor":"Furiex Pharmaceuticals, Inc","briefTitle":"Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)","officialTitle":"A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-05-29","primaryCompletion":"2014-07-29","completion":"2014-07-29","firstPosted":"2012-03-14","resultsPosted":"2018-09-04","lastUpdate":"2018-09-04"},"enrollment":1282,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Irritable Bowel Syndrome"],"interventions":[{"type":"DRUG","name":"Eluxadoline","otherNames":["JNJ-27018966"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Eluxadoline 75 mg","type":"EXPERIMENTAL"},{"label":"Eluxadoline 100 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine the efficacy, safety, and tolerability of different doses of eluxadoline (JNJ-27018966) compared with placebo in the treatment of participants with diarrhea-predominant irritable bowel syndrome.","primaryOutcome":{"measure":"Percentage of Participants Who Were Composite Responders Based on Improvements From Baseline in Daily Worst Abdominal Pain And Daily Stool Consistency Scores","timeFrame":"Up to 12 Weeks","effectByArm":[{"arm":"Eluxadoline 75 mg","deltaMin":23.9,"sd":null},{"arm":"Eluxadoline 100 mg","deltaMin":25.1,"sd":null},{"arm":"Placebo","deltaMin":17.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.014"},{"comp":"OG001 vs OG002","p":"0.004"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":283,"countries":["United States","Canada","United Kingdom"]},"refs":{"pmids":["28167156","26789872"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":25,"n":428},"commonTop":["Nausea","Constipation","Upper respiratory tract infection","Vomiting"]}}